TI
SILK

Trexquant Investment’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Trexquant Investment’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-188,668
Closed -$5.1M – 1941
2024
Q2 		$5.1M Buy
188,668
+176,724
+1,480% +$3.68M 0.08% 401
2024
Q1 		$219K Buy
+11,944
New +$190K ﹤0.01% 1349
2023
Q4 		– Sell
-14,865
Closed -$223K – 1879
2023
Q3 		$223K Sell
14,865
-19,787
-57% -$412K 0.01% 1314
2023
Q2 		$1.13M Sell
34,652
-36,535
-51% -$1.33M 0.03% 717
2023
Q1 		$2.79M Buy
71,187
+54,438
+325% +$2.66M 0.08% 348
2022
Q4 		$885K Buy
+16,749
New +$816K 0.03% 689
2021
Q3 		– Sell
-5,635
Closed -$270K – 1571
2021
Q2 		$270K Sell
5,635
-735
-12% -$37.4K 0.02% 765
2021
Q1 		$323K Buy
+6,370
New +$354K 0.03% 711
2020
Q3 		– Sell
-7,209
Closed -$302K – 1592
2020
Q2 		$302K Buy
+7,209
New +$277K 0.02% 881

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Trexquant Investment's SILK Position: Q3 2024 in Review

Trexquant Investment sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 188,668 shares — an estimated $5.1M sold.

Trexquant Investment first reported a position in SILK in Q2 2020 and held it in 9 quarters. The position peaked at $5.1M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Trexquant Investment reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Trexquant Investment sold 188,668 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $5.1M.
  • Trexquant Investment first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
  • Trexquant Investment's Silk Road Medical, Inc. Common Stock position peaked at $5.1M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Trexquant Investment's 13F filing for Q3 2024, filed 12 Nov 2024.